Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rui Bai

Showing results (371-380 of 378) with videos related to

Pageof 38
Sort By:
You have reached the last page of results.This site can display upto 378 results.
European Journal of Medicinal Chemistry|April 16, 2017
Identification of 3-substituted-6-(1-(1H-[1,2,3]triazolo[4,5-b]pyrazin-1-yl)ethyl)quinoline derivatives as highly potent and selective mesenchymal-epithelial transition factor (c-Met) inhibitors via metabolite profiling-based structural optimizationFei Zhao, Le-Duo Zhang, Yu Hao, et al.
Journal of Extracellular Vesicles|November 11, 2025
Efficient Scaling up EV-AAVs Production via Cellular Nanoporation for Familial Hypercholesterolaemia TherapyYuting Yan, Yi You, Shuhong Ma, et al.
Veterinary Parasitology|September 1, 2024
EtROP38 suppresses apoptosis of host cells infected with Eimeria tenella by inhibition of the p38MAPK pathwayBu-Ting Duan, Hao-Yu Zhang, Zi-Hao Song, et al.
Journal of Molecular and Cellular Cardiology|December 29, 2024
KLF2-dependent transcriptional regulation safeguards the heart against pathological hypertrophyYongqi Wu, Yujuan Song, Nan Xie, et al.
European Heart Journal|January 20, 2025
Extracellular vesicle-mediated VEGF-A mRNA delivery rescues ischaemic injury with low immunogenicityYi You, Yu Tian, Rui Guo, et al.
Gigascience|October 20, 2017
Panax ginseng genome examination for ginsenoside biosynthesisJiang Xu, Yang Chu, Baosheng Liao, et al.
The Lancet. Oncology|April 15, 2021
Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised, controlled, phase 3 trialXing Lv, Xun Cao, Wei-Xiong Xia, et al.
Nature Communications|February 10, 2026
Final survival analysis of induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by concurrent chemoradiotherapy in nasopharyngeal carcinoma: a multicenter, randomized, phase 3 trialXun Cao, Jia-Yu Zhou, Hao-Yang Huang, et al.
Pageof 38

Showing results (371-380 of 378) with videos related to

Sort By:
Pageof 38
You have reached the last page of results.This site can display upto 378 results.
European Journal of Medicinal Chemistry|April 16, 2017
Identification of 3-substituted-6-(1-(1H-[1,2,3]triazolo[4,5-b]pyrazin-1-yl)ethyl)quinoline derivatives as highly potent and selective mesenchymal-epithelial transition factor (c-Met) inhibitors via metabolite profiling-based structural optimizationFei Zhao, Le-Duo Zhang, Yu Hao, et al.
Journal of Extracellular Vesicles|November 11, 2025
Efficient Scaling up EV-AAVs Production via Cellular Nanoporation for Familial Hypercholesterolaemia TherapyYuting Yan, Yi You, Shuhong Ma, et al.
Veterinary Parasitology|September 1, 2024
EtROP38 suppresses apoptosis of host cells infected with Eimeria tenella by inhibition of the p38MAPK pathwayBu-Ting Duan, Hao-Yu Zhang, Zi-Hao Song, et al.
Journal of Molecular and Cellular Cardiology|December 29, 2024
KLF2-dependent transcriptional regulation safeguards the heart against pathological hypertrophyYongqi Wu, Yujuan Song, Nan Xie, et al.
European Heart Journal|January 20, 2025
Extracellular vesicle-mediated VEGF-A mRNA delivery rescues ischaemic injury with low immunogenicityYi You, Yu Tian, Rui Guo, et al.
Gigascience|October 20, 2017
Panax ginseng genome examination for ginsenoside biosynthesisJiang Xu, Yang Chu, Baosheng Liao, et al.
The Lancet. Oncology|April 15, 2021
Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised, controlled, phase 3 trialXing Lv, Xun Cao, Wei-Xiong Xia, et al.
Nature Communications|February 10, 2026
Final survival analysis of induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by concurrent chemoradiotherapy in nasopharyngeal carcinoma: a multicenter, randomized, phase 3 trialXun Cao, Jia-Yu Zhou, Hao-Yang Huang, et al.
Pageof 38